Dose-dependent neurorestorative effects of delayed treatment of traumatic brain injury with recombinant human erythropoietin in rats
- 1 September 2011
- journal article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 115 (3), 550-560
- https://doi.org/10.3171/2011.3.jns101721
Abstract
Delayed (24 hours postinjury) treatment with erythropoietin (EPO) improves functional recovery following experimental traumatic brain injury (TBI). In this study, the authors tested whether therapeutic effects of delayed EPO treatment for TBI are dose dependent in an attempt to establish an optimal dose paradigm for the delayed EPO treatment. Experimental TBI was performed in anesthetized young adult male Wistar rats using a controlled cortical impact device. Sham animals underwent the same surgical procedure without injury. The animals (8 rats/group) received 3 intraperitoneal injections of EPO (0, 1000, 3000, 5000, or 7000 U/kg body weight, at 24, 48, and 72 hours) after TBI. Sensorimotor and cognitive functions were assessed using a modified neurological severity score and foot fault test, and Morris water maze tests, respectively. Animals were killed 35 days after injury, and the brain sections were stained for immunohistochemical analyses. Compared with the saline treatment, EPO treatment at doses from 1000 to 7000 U/kg did not alter lesion volume but significantly reduced hippocampal neuron loss, enhanced angiogenesis and neurogenesis in the injured cortex and hippocampus, and significantly improved sensorimotor function and spatial learning. The animals receiving the medium dose of 5000 U/kg exhibited a significant improvement in histological and functional outcomes compared with the lower or higher EPO dose groups. These data demonstrate that delayed (24 hours postinjury) treatment with EPO provides dose-dependent neurorestoration, which may contribute to improved functional recovery after TBI, implying that application of an optimal dose of EPO is likely to increase successful preclinical and clinical trials for treatment of TBI.Keywords
This publication has 69 references indexed in Scilit:
- Sprouting of corticospinal tract axons from the contralateral hemisphere into the denervated side of the spinal cord is associated with functional recovery in adult rat after traumatic brain injury and erythropoietin treatmentBrain Research, 2010
- Vascular Endothelial Growth Factor Increases Neurogenesis after Traumatic Brain InjuryJournal of Cerebral Blood Flow & Metabolism, 2010
- Therapeutic effects of erythropoietin on histological and functional outcomes following traumatic brain injury in rats are independent of hematocritBrain Research, 2009
- Multifunctional Drug Treatment in NeurotraumaNeurotherapeutics, 2009
- Survival and proliferative roles of erythropoietin beyond the erythroid lineageExpert Reviews in Molecular Medicine, 2008
- Histological and functional outcomes after traumatic brain injury in mice null for the erythropoietin receptor in the central nervous systemBrain Research, 2008
- Ischemic stroke and neurogenesis in the subventricular zoneNeuropharmacology, 2008
- Role of gender in outcome after traumatic brain injury and therapeutic effect of erythropoietin in miceBrain Research, 2007
- Behavioral tests for preclinical intervention assessmentNeuroRX, 2006
- Neurorestorative treatment of stroke: Cell and pharmacological approachesNeuroRX, 2006